Therapeutic Leukocytapheresis and Adsorptive Cytapheresis

Staley, Elizabeth M.; Schwartz, Joseph; Pham, Huy P.

doi:10.1016/b978-0-12-813726-0.00078-7

Search citation statements

Order By: Relevance

Paper Sections

Select...

Principles Of Apheresis In Ibd1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2021

Publication Types

Select...

Book1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Subsequent models for apheresis incorporated a filter or a column for the selective removal of certain blood components. Currently, there are two leukocyte adsorptive devices available for apheresis in IBD patients [6,8]:…”

Section: Principles Of Apheresis In Ibdmentioning

confidence: 99%

Apheresis in Inflammatory Bowel Disease: Current Evidence

Vasile¹,

Jinga²

2021

Crohn’s Disease Recent Advances

View full text Add to dashboard Cite

Inflammatory bowel diseases (IBD) have become a major focus for gastroenterologists worldwide, with the increasing incidence and complexity of cases, which pose therapeutic challenges. Currently available approaches fail in controlling the disease activity in a significant proportion of patients and some of the therapies are associated with significant adverse events. Although new molecules are on the horizon and treatment strategies have been optimized, novel therapeutic tools are much needed in IBD for patients who fail to attain control of the disease. Apheresis is now a common non-pharmacological therapeutic modality used in several pathologies, IBD also. In the current review, we summarize currently available evidence with respect to selective apheresis in IBD.

show abstract

Section: Principles Of Apheresis In Ibdmentioning

confidence: 99%